Moberg Pharma AB (OSTO:MOB) Payments of Debt: kr0.00 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:MOB Moberg Pharma AB OSTO:MOB
59 GF Score
Price kr9.25
GF Value kr12.45
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Moberg Pharma AB Payments of Debt?

Moberg Pharma AB OSTO:MOB -1.07% 59 Payments of Debt is kr0.00 Mil as of Mar. 2026. GuruFocus rates OSTO:MOB with a GF Score™ of 59/100 and a GF Value™ of kr12.45 (Modestly Undervalued). The stock has 1 warning sign investors should review.

Moberg Pharma AB's Payments of Debt for the three months ended in Mar. 2026 was kr0.00 Mil.

Moberg Pharma AB's Payments of Debt for the trailing twelve months (TTM) ended in Mar. 2026 was kr0.00 Mil.

Moberg Pharma AB Payments of Debt Related Terms

Moberg Pharma AB Payments of Debt Historical Data

* Premium members only.

The historical data trend for Moberg Pharma AB's Payments of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Moberg Pharma AB Payments of Debt Chart

Moberg Pharma AB Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec21 Dec22 Dec23 Dec24
Payments of Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Moberg Pharma AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Payments of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
OSTO:MOB
59GF Score
Moberg Pharma AB OSTO:MOB
Payments of Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Moberg Pharma AB Payments of Debt Calculation

Payments of Debt represents all the cash outflow from debt, including both long-term debt and short-term debt.

Payments of Debt for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Payments of Debt →
What does a Payments of Debt of kr0.00 Mil mean?
Moberg Pharma AB (OSTO:MOB) has a Payments of Debt of kr0.00 Mil as of Mar. 2026. Payments of Debt is all the cash outflow from debt, including both long-term debt and short-term debt. View historical data on Moberg Pharma AB and its competitors.
Is Moberg Pharma AB's Payments of Debt too high?
Moberg Pharma AB's current Payments of Debt is kr0.00 Mil. Overall, Moberg Pharma AB has a GF Score™ of 59/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Moberg Pharma AB's Payments of Debt compare to ZTS and UTHR?
Moberg Pharma AB's Payments of Debt of kr0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Payments of Debt for a Drug Manufacturers company?
A good Payments of Debt depends on the Drug Manufacturers industry context. However, Payments of Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Payments of Debt mean?
A high Payments of Debt can signal that a stock is expensive relative to its fundamentals. Payments of Debt is all the cash outflow from debt, including both long-term debt and short-term debt. View historical data on Moberg Pharma AB and its competitors. Moberg Pharma AB's current Payments of Debt is kr0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Moberg Pharma AB stock overvalued right now?
Based on GuruFocus' analysis, Moberg Pharma AB (OSTO:MOB) is currently considered Modestly Undervalued. The stock's GF Value™ is kr12.45, compared to a current price of kr9.25 — trading 25.7% below its estimated fair value. The current Payments of Debt is kr0.00 Mil. Moberg Pharma AB's overall GF Score™ is 59/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Payments of Debt calculated?
Payments of Debt is calculated from a company's financial statements. For Moberg Pharma AB (OSTO:MOB), the current Payments of Debt is kr0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Moberg Pharma AB (OSTO:MOB) Overvalued in 2026?

Based on GuruFocus' analysis, Moberg Pharma AB stock appears to be undervalued. The current stock price of kr9.25 is trading 25.7% below its estimated GF Value™ of kr12.45. GuruFocus considers Moberg Pharma AB to be Modestly Undervalued.

Key valuation signals for OSTO:MOB:

  • Payments of Debt: kr0.00 Mil
  • GF Value™: kr12.45 vs. price of kr9.25 (25.7% below fair value)
  • GF Score™: 59/100 with 1 warning sign

No single metric tells the full story. See the OSTO:MOB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Moberg Pharma AB Business Description

Other Exchanges MBGPF:USA
Address Gustavslundsvagen 42, 5th Floor, Bromma, Stockholm, SWE, SE-167 51
Moberg Pharma AB is a Swedish pharmaceutical company which develops and commercializes proprietary pharmaceuticals based on proven substances. The company develops and markets consumer healthcare products that relieve pain and treat skin conditions, mainly nail fungus. The Company's main product, MOB-015, is a novel topical treatment for onychomycosis It has a single operating segment, the development, and commercialization of medical products. Its geographic areas are Europe, the Americas, and Rest of the world.
59GF Score

Get the complete analysis for OSTO:MOB

Payments of Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr9.25
Price
kr12.45
GF Value